Patents by Inventor Gaby Tresch

Gaby Tresch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Designed ankyrin repeat proteins binding to hepatocyte growth factor
    Patent number: 11453708
    Abstract: New designed ankyrin repeat proteins with binding specificity for HGF are described, as well as nucleic acids encoding such HGF binding proteins, pharmaceutical compositions comprising such proteins and the use of such proteins in the treatment of diseases.
    Type: Grant
    Filed: June 2, 2014
    Date of Patent: September 27, 2022
    Assignee: MOLECULAR PARTNERS AG
    Inventors: Gaby Tresch, Talitha Bakker, Douglas Phillips, Frieder W. Merz, Kaspar H. Binz
  • DESIGNED ANKYRIN REPEAT PROTEINS BINDING TO HEPATOCYTE GROWTH FACTOR
    Publication number: 20160251404
    Abstract: New designed ankyrin repeat proteins with binding specificity for HGF are described, as well as nucleic acids encoding such HGF binding proteins, pharmaceutical compositions comprising such proteins and the use of such proteins in the treatment of diseases.
    Type: Application
    Filed: June 2, 2014
    Publication date: September 1, 2016
    Applicant: MOLECULAR PARTNERS AG
    Inventors: Gaby TRESCH, Talitha BAKKER, Douglas PHILLIPS, Frieder W. MERZ, Kaspar H. BINZ
  • IL4/IL13 binding repeat proteins and uses
    Patent number: 9206244
    Abstract: IL4/IL13-binding proteins comprise binding domains, which inhibit IL4/IL13 binding to IL4Ralpha and common gamma chain complexes (Type 1) and inhibit IL4 binding to IL4Ralpha and IL13Ralpha1 complexes (Type 2), and IL13 binding to IL13Ralpha1 and/or IL13Ralpha2, are useful in the treatment of cancer, inflammatory, and other pathological conditions, such as allergic or fibrotic conditions, especially pulmonary conditions.
    Type: Grant
    Filed: March 26, 2014
    Date of Patent: December 8, 2015
    Assignee: Janssen Biotech, Inc.
    Inventors: Michael Baumann, Gaby Tresch, Steven Jacobs, Karyn O'Neil
  • IL4/IL13 Binding Repeat Proteins and Uses
    Publication number: 20140206599
    Abstract: IL4/IL13-binding proteins comprise binding domains, which inhibit IL4/IL13 binding to IL4Ralpha and common gamma chain complexes (Type 1) and inhibit IL4 binding to IL4Ralpha and IL13Ralpha1 complexes (Type 2), and IL13 binding to IL13Ralpha1 and/or IL13Ralpha2, are useful in the treatment of cancer, inflammatory, and other pathological conditions, such as allergic or fibrotic conditions, especially pulmonary conditions.
    Type: Application
    Filed: March 26, 2014
    Publication date: July 24, 2014
    Applicant: Janssen Biotech, Inc.
    Inventors: Michael Baumann, Gaby Tresch, Steven Jacobs, Karyn O'Neil